Novel dual-targeting drug could become a next-generation treatment for EBV-related cancers
A Hong Kong Baptist University-led (HKBU) research team has developed a novel drug which has the pot...
COVID-19 CG tracks local SARS-CoV-2 mutations by geographical location
Genomic surveillance of acute respiratory syndrome...
New SARS-CoV-2 B.1.526 variant emerges in New York
New York has the first case of a new severe acute ...
Antibody and T cell response to SARS-CoV-2 persist up to 8 months: Study of Ski Resort Ischgl
The first instance of the severe acute respiratory...
Research predicts which mammal species can spread SARS-CoV-2
Scientists worldwide are fighting to contain the o...
Researchers report a new SARS-CoV-2 variant of concern in Uganda
The etiological agent of the coronavirus disease 2...
Scientists discover new immunotherapy target for malignant brain tumors
Scientists say they have discovered a potential ne...
